| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.04 |